NCT00946790View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 1993

Primary Completion Date

December 31, 1993

Study Completion Date

December 31, 1993

Conditions
ImmunosuppressionRheumatism
Interventions
DRUG

Hydroxychloroquine Sulfate Tablets, 200 mg (Geneva Pharmaceutical, Inc.)

DRUG

Hydroxychloroquine Sulfate Tablets, 200 mg, Plaquenil (Sanofi Winthrop)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946790 - To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets | Biotech Hunter | Biotech Hunter